Ur Metser, MD, FRCPC

Core Lead, Techna Institute for the Advancement of Technology for Health (Techna)

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Keywords: molecular imaging, magnetic resonance imaging (MRI), medical imaging, radiation therapy

Clinical applications of functional imaging in oncology
Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
Novel radiopharmaceuticals targeting tumors
Metabolic response assessment to therapy

Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.

Ann Nucl Med. 2018 Jun 20;:

Parvez A, Tau N, Hussey D, Maganti M, Metser U

718F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.

Ann Nucl Med. 2018 May 12;:

Parvez A, Tau N, Hussey D, Maganti M, Metser U

Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside.

Int J Radiat Oncol Biol Phys. 2018 Mar 02;:

Han K, Shek T, Vines D, Driscoll B, Fyles A, Jaffray D, Keller H, Metser U, Pintilie M, Xie J, Yeung I, Milosevic M

18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.

Br J Radiol. 2018 Mar 02;:20170814

H St A E, U M, M P, J C, P B, P VH, D H, N T

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.

J Surg Oncol. 2018 Feb;117(2):213-219

Loveday BPT, Knox JJ, Dawson LA, Metser U, Brade A, Horgan AM, Gallinger S, Greig PD, Moulton CA

Administration of Hypoxia-Activated Prodrug Evofosfamide after Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Colorectal Cancer.

Clin Cancer Res. 2018 Feb 23;:

Haynes J, McKee TD, Haller AC, Wang Y, Leung C, Gendoo DMA, Lima-Fernandes E, Kreso A, Wolman R, Szentgyorgyi E, Vines DC, Haibe-Kains B, Wouters BG, Metser U, Jaffray DA, Smith M, O'Brien CA

18F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer.

AJR Am J Roentgenol. 2018 Jan 11;:1-6

Metser U, Berlin A, Halankar J, Murphy G, Jhaveri KS, Ghai S, Tau N

Cystic lesions of the pancreatico-biliary tree: A schematic MRI approach.

Indian J Radiol Imaging. 2017 Apr-Jun;27(2):167-176

Halankar J, Jhaveri K, Metser U

Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.

Semin Nucl Med. 2017 Jul;47(4):352-361

Metser U, Tau N

Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.

Ann Nucl Med. 2017 Mar 28;:

Singnurkar A, Poon R, Metser U